IL149101A0 - Pharmaceutical formulation containing tolterodine and its use - Google Patents

Pharmaceutical formulation containing tolterodine and its use

Info

Publication number
IL149101A0
IL149101A0 IL14910100A IL14910100A IL149101A0 IL 149101 A0 IL149101 A0 IL 149101A0 IL 14910100 A IL14910100 A IL 14910100A IL 14910100 A IL14910100 A IL 14910100A IL 149101 A0 IL149101 A0 IL 149101A0
Authority
IL
Israel
Prior art keywords
pharmaceutical formulation
formulation containing
containing tolterodine
tolterodine
pharmaceutical
Prior art date
Application number
IL14910100A
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/SE1999/002052 external-priority patent/WO2000027364A1/en
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority claimed from PCT/SE2000/002061 external-priority patent/WO2001034139A1/en
Publication of IL149101A0 publication Critical patent/IL149101A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14910100A 1999-11-11 2000-10-24 Pharmaceutical formulation containing tolterodine and its use IL149101A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/SE1999/002052 WO2000027364A1 (en) 1998-11-11 1999-11-11 New controlled release bead, a method of producing the same and multiple unit formulation comprising it
SE0000782A SE0000782D0 (en) 1999-11-11 2000-03-09 Pharmaceutical formulation and its use
PCT/SE2000/002061 WO2001034139A1 (en) 1999-11-11 2000-10-24 Pharmaceutical formulation containing tolterodine and its use

Publications (1)

Publication Number Publication Date
IL149101A0 true IL149101A0 (en) 2002-11-10

Family

ID=26655013

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14910100A IL149101A0 (en) 1999-11-11 2000-10-24 Pharmaceutical formulation containing tolterodine and its use

Country Status (2)

Country Link
IL (1) IL149101A0 (en)
SE (1) SE0000782D0 (en)

Also Published As

Publication number Publication date
SE0000782D0 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
HUP0203028A3 (en) Pharmaceutical formulation containing tolterodine and its use
HUP0200831A3 (en) Novel pharmaceutical composition containing amoxycillin and its use
HUP0200548A2 (en) Pharmaceutical compositions and their use
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
HUP0203895A3 (en) Substituted azaindoles and pharmaceutical compositions containing them and their use
HK1040995A1 (en) 2-oxoquinoline compounds and medicinal uses thereof
HUP0202338A2 (en) Pharmaceutical composition containing fenofibrate and preparation method
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
GB0101035D0 (en) Formulation and use thereof
IL145715A0 (en) Formulation arrays and use thereof
HUP0104034A3 (en) Dosage form comprising liquid formulation
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
HUP0101733A3 (en) Pharmaceutical compositions containing sulfonyl-dipeptides and their use
GB9818927D0 (en) Pharmaceutical formulation
HK1044947A1 (en) Benzamide derivatives and drugs containing the same
GB9909154D0 (en) Pharmaceutical formulation
HUP0200812A3 (en) Vitamin d analogues and their pharmaceutical use
EP1154783A4 (en) Medicaments comprising relaxin and their use
HUP0200336A2 (en) Pharmaceutical effervescent formulation containing metamizol
IL149101A0 (en) Pharmaceutical formulation containing tolterodine and its use
GB9926251D0 (en) Pharmaceutical formulation
ZA200202767B (en) Pharmaceutical formulation containing tolterodine and its use.
GB9802617D0 (en) Pharmaceutical formulation